WallStreetZenWallStreetZen

NASDAQ: RANI
Rani Therapeutics Holdings Inc Stock

$3.59+0.30 (+9.12%)
Updated Jul 11, 2024
RANI Price
$3.59
Fair Value Price
-$0.93
Market Cap
$181.01M
52 Week Low
$1.82
52 Week High
$8.75
P/E
-2.78x
P/B
24.47x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$33.08M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
5.27
Operating Cash Flow
-$48M
Beta
0.78
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

RANI Overview

Rani Therapeutics Holdings, Inc. is as a clinical stage biotherapeutics company developing orally administered biologics. Its product pipeline includes RT-101 for the treatment of neuroendocrine tumors and acromegaly, RT-105 to treat psoriatic arthritis, and RT-102 to treat osteoporosis. The company is also developing the RaniPill capsule, a platform intended to replace subcutaneous or IV injection of biologics with oral dosing. Rani Therapeutics was incorporated in 2012 and is headquartered in San Jose, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RANI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RANI ($3.59) is overvalued by 485.77% relative to our estimate of its Fair Value price of -$0.93 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
RANI ($3.59) is not significantly undervalued (485.77%) relative to our estimate of its Fair Value price of -$0.93 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
RANI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more RANI due diligence checks available for Premium users.

Be the first to know about important RANI news, forecast changes, insider trades & much more!

RANI News

Valuation

RANI fair value

Fair Value of RANI stock based on Discounted Cash Flow (DCF)
Price
$3.59
Fair Value
-$0.93
Undervalued by
485.77%
RANI ($3.59) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
RANI ($3.59) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
RANI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

RANI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.78x
Industry
-14.46x
Market
31.84x

RANI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
24.47x
Industry
6.37x
RANI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RANI's financial health

Profit margin

Revenue
$0.0
Net Income
-$7.5M
Profit Margin
0%
RANI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$53.5M
Liabilities
$39.0M
Debt to equity
5.27
RANI's short-term assets ($41.39M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RANI's short-term assets ($41.39M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RANI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.4M
Investing
$10.3M
Financing
$121.0k
RANI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RANI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
RANI$181.01M+9.12%-2.78x24.47x
SKYE$182.72M+6.90%-2.78x2.32x
INMB$178.83M+7.75%-4.71x6.34x
FENC$178.41M+8.83%72.56x59.19x
BMEA$178.29M+4.42%-1.39x1.32x

Rani Therapeutics Holdings Stock FAQ

What is Rani Therapeutics Holdings's quote symbol?

(NASDAQ: RANI) Rani Therapeutics Holdings trades on the NASDAQ under the ticker symbol RANI. Rani Therapeutics Holdings stock quotes can also be displayed as NASDAQ: RANI.

If you're new to stock investing, here's how to buy Rani Therapeutics Holdings stock.

What is the 52 week high and low for Rani Therapeutics Holdings (NASDAQ: RANI)?

(NASDAQ: RANI) Rani Therapeutics Holdings's 52-week high was $8.75, and its 52-week low was $1.82. It is currently -58.97% from its 52-week high and 97.25% from its 52-week low.

How much is Rani Therapeutics Holdings stock worth today?

(NASDAQ: RANI) Rani Therapeutics Holdings currently has 50,420,315 outstanding shares. With Rani Therapeutics Holdings stock trading at $3.59 per share, the total value of Rani Therapeutics Holdings stock (market capitalization) is $181.01M.

Rani Therapeutics Holdings stock was originally listed at a price of $11.00 in Jul 30, 2021. If you had invested in Rani Therapeutics Holdings stock at $11.00, your return over the last 2 years would have been -67.36%, for an annualized return of -42.87% (not including any dividends or dividend reinvestments).

How much is Rani Therapeutics Holdings's stock price per share?

(NASDAQ: RANI) Rani Therapeutics Holdings stock price per share is $3.59 today (as of Jul 11, 2024).

What is Rani Therapeutics Holdings's Market Cap?

(NASDAQ: RANI) Rani Therapeutics Holdings's market cap is $181.01M, as of Jul 12, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Rani Therapeutics Holdings's market cap is calculated by multiplying RANI's current stock price of $3.59 by RANI's total outstanding shares of 50,420,315.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.